Cerin Daniel
Neurology with Special Qualifications in Child Neurology · Plano, TXNPI 1285098426
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $887, 5.5 times the $160 reported in 2022.
Across 71 payments — averaging $22.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurelis, Inc.$299
- Livanova USA, Inc.$250
- UCB, Inc.$155
- Corium, LLC$152
- Jazz Pharmaceuticals Inc.$143
- Acadia Pharmaceuticals Inc$125
- plus $491 from 15 others
What the payments were for
- Food & beverage$1,615100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurelis, Inc. | 13 | $299 |
| Livanova USA, Inc. | 8 | $250 |
| UCB, Inc. | 8 | $155 |
| Corium, LLC | 6 | $152 |
| Jazz Pharmaceuticals Inc. | 6 | $143 |
| Acadia Pharmaceuticals Inc | 8 | $125 |
| Azurity Pharmaceuticals, Inc. | 2 | $67 |
| Biogen | 3 | $55 |
| Tris Pharma Inc | 3 | $48 |
| Teva Pharmaceuticals USA, Inc. | 1 | $44 |
| Noven Therapeutics, LLC | 2 | $38 |
| Orchard Therapeutics North America | 1 | $31 |
| Sumitomo Pharma America, Inc. | 2 | $30 |
| Aucta Pharmaceuticals, Inc. | 1 | $29 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $28 |
| SK Life Science, Inc. | 1 | $27 |
| Aprecia Pharmaceuticals, LLC | 1 | $20 |
| Neos Therapeutics, LP | 1 | $19 |
| Upsher-smith Laboratories LLC | 1 | $19 |
| Aquestive Therapeutics, Inc. | 1 | $18 |
| Catalyst Pharmaceuticals, Inc. | 1 | $18 |
How this compares
$1,615 in reported general payments places this provider in the 55th percentile of 193 neurology with special qualifications in child neurology providers in Texas.
See all neurology with special qualifications in child neurology providers in Texas →
Other neurology with special qualifications in child neurology in Plano
- Robert ChudnowPlano$13K
- Safiullah ShareefPlano$11K
- Andrew HurdPlano$10K
- Mohsin MaqboolPlano$8K
- Lina ShahPlano$6K
- Gerald SoPlano$5K
- Patricia MirelesPlano$3K
- Roy EltermanDallas$5.9M
- Huda ZoghbiHouston$5.5M
- Diana CastroDenton$343K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.